Glaucoma Progression Tracking
Glaucoma Progression Tracking - Related Videos
05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
0 Views •
Cited by 17 •
2018
Glaucoma is a chronic disease with progressive degeneration of optic nerve fibers resulting in decreased visual field. Elevated intraocular pressure is considered the most important and the only treatable risk factor. This manuscript describes a simple, surgeon-friendly, non-incisional technique, named Ultrasound Cyclo Plasty, for reducing intraocular pressure in glaucoma patients.
12:48
In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
0 Views •
Cited by 29 •
2015
Microglia activation and microgliosis are key responses to chronic neurodegeneration. Here, we present methods for in vivo, long-term visualization of retinal CX3CR1-GFP+ microglial cells by confocal ophthalmoscopy, and for threshold and morphometric analyses to identify and quantify their activation. We monitor microglial changes during early stages of age-related glaucoma.
10:55
Live Imaging Followed by Single Cell Tracking to Monitor Cell Biology and the Lineage Progression of Multiple Neural Populations
0 Views •
Cited by 12 •
2017
A robust protocol to monitor neural populations by time-lapse video-microscopy followed by software-based post-processing is described. This method represents a powerful tool to identify biological events in a selected population during live imaging experiments.
04:55
In Vivo Imaging of Retinal Microglia in a Mouse Model of Glaucoma
0 Views •
2025
Source: Bosco, A., et al. In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma. J. Vis. Exp. (2015) This video demonstrates in vivo imaging of retinal microglia in a mouse model of glaucoma. A transgenic mouse with fluorescent protein-expressing retinal microglia is positioned under an ophthalmoscope. Infrared illumination is used to locate the optic nerve head (ONH), and the focal plane is...
08:52
Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization
0 Views •
Cited by 7 •
2015
This protocol describes the use of bromodeoxyuridine (BrdU) uptake to permit the temporal tracking of cells that were in S phase at a specific point in time. Addition of DNA dyes and antibody labeling facilitates detailed analysis of the fate of the S phase cells at later times.
FAQs
Repeated measurements reveal whether changes persist over time rather than reflecting normal measurement variability in a single test. Comparing results longitudinally allows trend analysis to identify a consistent pattern of worsening optic nerve damage or vision loss. This approach makes the assessment more reliable and supports decisions about whether observed change may require closer management.
Optical coherence tomography provides structural measurements of the retinal nerve fiber layer, whereas visual field testing assesses functional changes associated with vision loss. Using both perspectives helps relate tissue changes to visual performance. Their combination gives progression tracking a broader basis than relying on either structural imaging or functional testing alone.
A meaningful trend depends on changes that are consistent across repeated assessments and distinguishable from normal measurement variability. Trend analysis provides the framework for interpreting whether measurements indicate actual worsening rather than random fluctuation. This distinction is important because progression tracking is intended to support timely evaluation of optic nerve damage and vision loss.
Bioengineering contributes imaging systems, sensors, and computational models that can improve the precision, speed, and interpretation of repeated eye assessments. These technologies strengthen the measurement and analysis pipeline rather than replacing clinical evaluation. Better technical performance can help identify changes more reliably and support individualized decisions about intraocular pressure management.
The workflow begins with repeated optical coherence tomography and visual field measurements, followed by analysis of their trends over time. Structural retinal nerve fiber layer results can be considered alongside functional visual field findings to evaluate whether change is consistent. The resulting assessment can then inform treatment evaluation and future management decisions.
Tracking is particularly useful when clinicians need to determine whether disease-related change is occurring, evaluate the effectiveness of treatment, or decide how to manage intraocular pressure. Longitudinal evidence supports earlier detection of progression and helps guide personalized decisions. It also provides a basis for considering future neuroprotective strategies as they become relevant.
Longitudinal tracking can show the direction and persistence of structural and functional change, helping distinguish stable findings from worsening disease. It may therefore support earlier recognition of progression, assessment of treatment response, and more personalized management. In bioengineering, improved imaging and computational interpretation strengthen the usefulness of these outcomes for clinical decisions.
The topic connects clinical needs with engineering challenges in imaging, sensing, and computational analysis. Bioengineering research can focus on making measurements more precise and faster while improving interpretation of longitudinal data. These advances are relevant because reliable progression evidence supports treatment evaluation, intraocular pressure management, and development of future neuroprotective strategies.